Jordan Sudberg Patients and doctors who are navigating the difficult process of figuring out how to manage pain safely and effectively are right to be optimistic. In what is'very positive' health announcement, it was reported today it was announced that TR Processing, a botanical-derivative manufacturer, was selected as an Cannabidiol (CBD) supplier in the purpose of a clinical study evaluating CBD safety and its impact on post-operative pain. Further options for managing pain could be on coming days.
In order for medical advances to be made patients need innovative treatments and medications to manage the pain. What's required to improve outcomes for patients is a variety of options for treating pain and treatment. The there has been a slow pace to progress. Health care professionals and policymakers have been battling to manage the devastating opioid crisis that is sweeping across America. The most recent data on fatal drug overdoses by the Centers for Disease Control and Prevention (CDC) confirms that America has suffered more than 100,000 fatal overdose deaths in 2021.
The shocking overdose statistics are the result of the 2016 CDC guidelines for prescribing opioids to treat chronic pain was published. The CDC recommendations were made to tackle the issue of overdose. The problem of addiction has only grown worse. The estimated death toll of 108,000 in 2021 are a significantly more than the 2017 number which was the year that President Trump declared deaths from drugs an emergency in public health. With the rise of pain management, opioid prescriptions, and overdoses we've been slowly moving in the opposite direction - i.e. in going in the opposite direction.
Jordan Sudberg central point of the CDC's 2016 guidance report was the suggestion to limit the amount of opioid prescriptions that doctors are able to give. As a result, many doctors worried about possible negative effects have shifted their patients off the medication which have proven effective in helping manage the pain. We are facing the most dangerous of both. This means that we are seeing there are more overdoses of opioids, even when the doctors cease prescribing opioids for patients who urgently require them.
The doctors Richard Menger and Jeffrey Singer have recently written in Reason:
"Because the medical and government boards restrict surgeons' ability prescription of opioids. surgeons like us, are unable to longer manage a patient's complicated pain with our best clinical judgement without the oversight of an administrative. This system creates a barrier between patients and doctors and creates a hostile atmosphere. It's not what we were expecting when we signed the Hippocratic swearing."
Jordan Sudberg TR processing/clinical trials announcements are a welcome announcement in the direction of medical advancement. The former president Bill Clinton - cited in the TR Processing press statement - stated, "The Clinton Foundation has been working for years to decrease the number of deaths and addictions to opioids. To achieve this, we require non-addictive options to manage pain. These results from the study carried out by NYU Langone, with TRP's CBD ingredient, are optimistic and I'm looking forward to hear about the outcomes of the following round."
The Opioid epidemic was raging in the background since the Covid-19 epidemic. Additionally that during the Covid crisis public health professionals were distracted by myriad of controversies that were unprecedented, ranging including extended lockdowns, school closures to cover up the mandates of nursing homes and nursing home guidelines. In addition to the pandemic-related debates are the CDC figures that show an increase of 100,000 deaths due to overdoses in 2021.
The latest techniques for ingredients, treatments and drugs are required... Yesterday. This is the reason why that the clinical trials of TR Processing and NYU Langone is good news today.
Comments
Post a Comment